Clomicalm

Clomipramine is a prescription medication used to treat symptoms of obsessive-compulsive disorder (OCD), a mental illness that causes people to have consistent worry and stressful thoughts that create a need to perform compulsive behaviors repeatedly. 

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Clomicalm is part of the drug class:

• Non selective monoamine reuptake inhibitors

Serious side effects have been reported with clomipramine. See the "Drug Precautions" section.

Common side effects of clomipramine include the following:

• dry mouth
• constipation
• nausea
• vomiting
• diarrhea
• dyspepsia (Indigestion)
• drowsiness
• dizziness
• nervousness
• headache
• changes in weight or eating habits
• changes in sexual desire

This is not a complete list of clomipramine side effects. Ask your doctor or pharmacist for more information.

Tell your doctor if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Clomicalm Tablets are contraindicated in dogs with known hypersensitivity to clomipramine or other tricyclic antidepressants.

Clomicalm Tablets should not be used in male breeding dogs. Testicular hypoplasia was seen in dogs treated for 1 year at 12.5 times the maximum daily dose.

Clomicalm Tablets should not be given in combination, or within 14 days before or after treatment with a monoamine oxidase inhibitor [e.g. selegiline hydrochloride (L-deprenyl),amitraz].

Clomicalm Tablets are contraindicated for use in dogs with a history of seizures or concomitantly with drugs which lower the seizure threshold.

Safety studies to determine the effects of Clomicalm Tablets in pregnant or lactating female dogs have not been conducted. Clomicalm Tablets should not be used in breeding males (See Contraindications).

Clomicalm Tablets are available in 5, 20, 40 and 80 mg tablet strengths in color-coded packaging for oral administration to dogs.

Keep this and all drugs out of reach of children.

Manufactured for:       Novartis Animal Health US, Inc.

Greensboro, NC 27408, USA

NADA # 141-120, Approved by FDA

© 2008 Novartis Animal Health US, Inc.      

Clomicalm is a registered trademark of Novartis AG.      

NAH/CLO-T/VI/6

10/08

Novartis Animal Health US, Inc. encourages you to take the time to read this package insert which describes the use of Clomicalm Tablets for the treatment of separation anxiety in conjunction with behavior modification (training) in dogs. Clomicalm Tablets do not act as a sedative. Instead, Clomicalm Tablets help to reduce the anxiety associated with this condition, thus allowing your dog to more effectively benefit from behavior training. After reading this insert, if you have any questions about the use of Clomicalm Tablets, please consult your veterinarian.

Clomicalm®

(clomipramine hydrochloride)

5 mg (2.75-10.9 lbs. body weight)

FOR USE IN DOGS ONLY

CAUTION: Federal (USA) law restricts this

drug to use by or on the order of a licensed veterinarian.

Net contents: 30 tablets

5 mg each

Product #40312

NOVARTIS

ANIMAL HEALTH